Jeff Yass’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-245,600
| Closed | -$4.36M | – | 10561 |
|
|
2018
Q3 | $4.36M | Buy |
245,600
+127,100
| +107% | +$2.18M | ﹤0.01% | 2845 |
|
|
2018
Q2 | $1.64M | Sell |
118,500
-21,900
| -16% | -$260K | ﹤0.01% | 4374 |
|
|
2018
Q1 | $1.28M | Buy |
140,400
+36,700
| +35% | +$202K | ﹤0.01% | 4743 |
|
|
2017
Q4 | $444K | Buy |
103,700
+70,100
| +209% | +$334K | ﹤0.01% | 6860 |
|
|
2017
Q3 | $47K | Sell |
33,600
-16,700
| -33% | -$23.3K | ﹤0.01% | 8556 |
|
|
2017
Q2 | $75K | Buy |
50,300
+10,800
| +27% | +$23.2K | ﹤0.01% | 8798 |
|
|
2017
Q1 | $102K | Buy |
39,500
+14,700
| +59% | +$34K | ﹤0.01% | 8385 |
|
|
2016
Q4 | $63K | Sell |
24,800
-8,400
| -25% | -$24.1K | ﹤0.01% | 9233 |
|
|
2016
Q3 | $103K | Buy |
33,200
+800
| +2% | +$2.49K | ﹤0.01% | 7930 |
|
|
2016
Q2 | $104K | Sell |
32,400
-13,400
| -29% | -$49.1K | ﹤0.01% | 8007 |
|
|
2016
Q1 | $142K | Sell |
45,800
-41,700
| -48% | -$136K | ﹤0.01% | 8246 |
|
|
2015
Q4 | $351K | Buy |
87,500
+11,200
| +15% | +$51.6K | ﹤0.01% | 7412 |
|
|
2015
Q3 | $349K | Sell |
76,300
-61,800
| -45% | -$323K | ﹤0.01% | 7773 |
|
|
2015
Q2 | $717K | Buy |
138,100
+19,000
| +16% | +$114K | ﹤0.01% | 6895 |
|
|
2015
Q1 | $746K | Sell |
119,100
-143,400
| -55% | -$828K | ﹤0.01% | 6336 |
|
|
2014
Q4 | $1.65M | Sell |
262,500
-79,800
| -23% | -$486K | ﹤0.01% | 4819 |
|
|
2014
Q3 | $2.08M | Buy |
342,300
+190,600
| +126% | +$1.3M | ﹤0.01% | 4547 |
|
|
2014
Q2 | $1M | Sell |
151,700
-334,300
| -69% | -$3.77M | ﹤0.01% | 6053 |
|
|
2014
Q1 | $11.6M | Buy |
486,000
+435,300
| +859% | +$6.31M | 0.01% | 1856 |
|
|
2013
Q4 | $542K | Buy |
50,700
+21,100
| +71% | +$233K | ﹤0.01% | 6562 |
|
|
2013
Q3 | $395K | Sell |
29,600
-28,900
| -49% | -$457K | ﹤0.01% | 6784 |
|
|
2013
Q2 | $768K | Buy |
+58,500
| New | +$789K | ﹤0.01% | 5411 |
|
Other funds holding ECYT
Jeff Yass's ECYT Position: Q2 2018 in Review
Jeff Yass sold out of Endocyte, Inc. Common Stock (ECYT) in Q2 2018, closing a stake of 499,801 shares — an estimated $5.93M sold.
Jeff Yass first reported a position in ECYT in Q2 2013 and held it in 19 quarters. The position peaked at $4.54M in Q1 2018. 114 funds tracked by Wall St. Rank hold ECYT as of Q2 2018.
- Jeff Yass reported no remaining Endocyte, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
- Jeff Yass sold 499,801 Endocyte, Inc. Common Stock shares in Q2 2018, an estimated $5.93M.
- Jeff Yass first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 19 quarters.
- Jeff Yass's Endocyte, Inc. Common Stock position peaked at $4.54M in Q1 2018.
- 114 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q2 2018.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.